CCR5 and infection: To this end, allo-HSCT components postulated to reduce viral reservoirs include pre-transplant conditioning regimens, protecting donor CD4+ T cells from infection with ART, graft-versus-host (GvH) responses, and donor HSCs lacking functional C-C chemokine receptor type 5 (CCR5)11,12.